Literature DB >> 10354350

Biochemical characterization and localization of Fasciola hepatica 26-28 kDa diagnostic coproantigen.

S Abdel-Rahman1, K L O'Reilly, J B Malone.   

Abstract

We have previously reported the usefulness of a 26-28 kDa coproantigen of Fasciola hepatica for diagnosis of infection. In this study, the 26-28 kDa coproantigen was biochemically characterized with the aid of monoclonal antibodies (MoAb) in an effort to better understand the biology of the antigen. Differential staining of chromatographically-purified 26-28 kDa coproantigen on SDS-PAGE, under reducing and non-reducing conditions, indicated that the coproantigen was a monomeric, highly glycosylated glycoprotein. Alkaline treatment of the purified coproantigen resulted in an 8 kDa protein core which still contained the epitope recognized by the MoAb. No protease activity was associated with the 26-28 kDa coproantigen. The coproantigen could be cleaved by trypsin without altering the reactive epitope recognized by the MoAb, but was resistant to pepsin digestion. Further, the coproantigen was stable under several different storage conditions. Indirect immunofluorescence on tissue sections of adult flukes indicated that the coproantigen was present in gut cells and tegument. Taken together these results confirm the stability of the 26-28 kDa coproantigen and its usefulness in diagnostic tests for F. hepatica infections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10354350     DOI: 10.1046/j.1365-3024.1999.00191.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  6 in total

1.  Characterisation of Fasciola gigantica adult 27-kDa excretory-secretory antigen in human fascioliasis.

Authors:  C Tantrawatpan; W Maleewong; C Wongkham; S Wongkham; P M Intapan; K Nakashima
Journal:  Parasitol Res       Date:  2003-09-12       Impact factor: 2.289

2.  Biochemical characterization and differential expression of a 16.5-kilodalton tegument-associated antigen from the liver fluke Fasciola hepatica.

Authors:  José F Gaudier; Kimberly Cabán-Hernández; Antonio Osuna; Ana M Espino
Journal:  Clin Vaccine Immunol       Date:  2012-01-25

3.  Evaluation of a 14.5 kDa-Fasciola gigantica fatty acid binding protein as a diagnostic antigen for human fascioliasis.

Authors:  Gamal Allam; Ibrahim R Bauomy; Zeinab M Hemyeda; Thabet F Sakran
Journal:  Parasitol Res       Date:  2011-11-24       Impact factor: 2.289

4.  Field evaluation of a coproantigen detection test for fascioliasis diagnosis and surveillance in human hyperendemic areas of Andean countries.

Authors:  María Adela Valero; María Victoria Periago; Ignacio Pérez-Crespo; René Angles; Fidel Villegas; Carlos Aguirre; Wilma Strauss; José R Espinoza; Patricia Herrera; Angelica Terashima; Hugo Tamayo; Dirk Engels; Albis Francesco Gabrielli; Santiago Mas-Coma
Journal:  PLoS Negl Trop Dis       Date:  2012-09-13

5.  Diagnostic efficacy of monoclonal antibody based sandwich enzyme linked immunosorbent assay (ELISA) for detection of Fasciola gigantica excretory/secretory antigens in both serum and stool.

Authors:  Zeinab A Demerdash; Tarek M Diab; Ibrahim R Aly; Salwa H Mohamed; Faten S Mahmoud; Mona K Zoheiry; Wafaa A Mansour; Mohy E Attia; Azza E El-Bassiouny
Journal:  Parasit Vectors       Date:  2011-09-15       Impact factor: 3.876

6.  Immunolocalization and immunodetection of the excretory/secretory (ES) antigens of Fasciola gigantica.

Authors:  M A Hannan Khan; Rizwan Ullah; Abdur Rehman; Lubna Rehman; Ahammed Shareef P A; S M A Abidi
Journal:  PLoS One       Date:  2017-10-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.